These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 13921881)

  • 1. Hypoglycaemic activity of N-benzenesulphonyl-N'-iso-propylurea and N-benzenesulphonyl-N'-n-butylurea in experimental animals.
    TONSE U; ANANTHANARAYANAN KG; MHASALKAR MY; SHAH MH; DELIWALA CV
    Nature; 1962 Mar; 193():891. PubMed ID: 13921881
    [No Abstract]   [Full Text] [Related]  

  • 2. [Potentiation of the effects of exogenous insulin by N-(4-methylbenzenesulfonyl)-N'-butylurea and N1-n-butylbiguanide in the eviscerated animal].
    CREUTZFELDT W; DEUTICKE U; SOELING HD
    Klin Wochenschr; 1961 Aug; 39():790-5. PubMed ID: 13696432
    [No Abstract]   [Full Text] [Related]  

  • 3. Potentiating the diabetogenic effect of alloxan by N-sulphonyl-N-butylurea (BZ-55).
    MOSINGER B; BRAUN T
    Experientia; 1959 Aug; 15():317-8. PubMed ID: 14424566
    [No Abstract]   [Full Text] [Related]  

  • 4. [FATTY LIVER PATHOGENESIS IN CARASSIUS AURATUS IN GLUCOSE-RICH MEDIUM AND ITS ALTERATION BY N1-N-BUTYLBIGUANIDE AND N'-(4-METHYLBENZOYLSULFONYL)-N'-BUTYLUREA (TOLBUTAMIDE)].
    KOEHLER E; LIPPMANN HG
    Acta Biol Med Ger; 1963; 11():866-72. PubMed ID: 14121880
    [No Abstract]   [Full Text] [Related]  

  • 5. [Influence of the autonomic nervous system on hyperglycemia from glucagon and hypoglycemia from N-(4-methyl-benzosulfonyl)-N'-butylurea].
    CAVALLERO C; MALANDRA B
    Acta Neuroveg (Wien); 1957; 16(1-4):196-9. PubMed ID: 13520327
    [No Abstract]   [Full Text] [Related]  

  • 6. [Action on the blood sugar level of some new N,N'-bisubstituted urea derivatives].
    SANSONE M; MARINARI UM; DELL'OMODARME G
    Gazz Med Ital; 1961 Oct; 120():384-6. PubMed ID: 14497010
    [No Abstract]   [Full Text] [Related]  

  • 7. [On the hypoglycemic activity of N-benzoylsulfonyl-N'-isopropylurea and N-benzoylsulfonyl-N'--p-butylurea].
    Genes SG; Plavskaia AA; Savin BM; Iavlinskiĭ MD
    Farmakol Toksikol; 1965; 28(1):91-2. PubMed ID: 5845058
    [No Abstract]   [Full Text] [Related]  

  • 8. The pharmacology of a new hypoglycaemic agent N-[4-(2-(2,3-dihydrobenzo(b)furan-m-carboxamido)-ethyl)-benzenesulphonyl]-N'-cyclohexylurea (NOVO CS 476). I. Pharmacological studies on the hypoglycaemic effect.
    Jorgensen KD
    Acta Pharmacol Toxicol (Copenh); 1977 Feb; 40(2):216-26. PubMed ID: 402791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacology of a new hypoglycaemic agent N-[4-(2-(2,3-dihydrobenzo (b) furan-7-carboxamido)-ethyl)-benzenesulphonyl]-N'-cyclohexylurea (NOVO CS 476). II. Pharmacological studies on the mechanism of action.
    Jorgensen KD
    Acta Pharmacol Toxicol (Copenh); 1977 Feb; 40(2):227-33. PubMed ID: 190857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacology of 1-(p-chlorobenzenesulfonyl)-3-n-propylurea (chlorpropamide).
    ROOT MA; SIGAL MV; ANDERSON RC
    Diabetes; 1959; 8(1):7-13. PubMed ID: 13619485
    [No Abstract]   [Full Text] [Related]  

  • 11. [The teratogenic action of a hypoglycemic sulfonylurea (N-sulfanilil-N-butylurea-BZ55)].
    De Meyer R; Isaac-Mathy M
    Ann Endocrinol (Paris); 1958; 19(1):167-72. PubMed ID: 13534005
    [No Abstract]   [Full Text] [Related]  

  • 12. The pharmacology of a new hypoglycaemic agent N-[4-(2-(2,3-dihydrobenzo(b)furan-7-carboxamid o)-ethyl)-benzenesulphonyl]-N'-cyclohexlurea (NOVO CS 476). III. General pharmacological studies.
    Jorgensen KD
    Acta Pharmacol Toxicol (Copenh); 1977 Feb; 40(2):234-40. PubMed ID: 402792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experimental research on the effects of N-4-methyl-benzolsulfonyl-N'-butyl urea on various enzymes of glycolysis: glucose-6-phosphatase, hexokinase and phosphoglucomutase].
    COLTORTI M; GIUSTI G; ASCIONE A
    Rass Fisiopatol Clin Ter; 1957 May; 29(3):283-9. PubMed ID: 13466087
    [No Abstract]   [Full Text] [Related]  

  • 14. [Study on the absence of antibacterial properties in a new synthetic antidiabetic, 1-(3-aminobenzenesulfonyl)-3-n-butylurea or SB 1].
    REGAMEY RH
    Schweiz Med Wochenschr; 1959 Nov; 89():1183-6. PubMed ID: 14436950
    [No Abstract]   [Full Text] [Related]  

  • 15. [First clinical trials of a new synthetic antidiabetic SB 1 or 1-(3-aminobenzenesulfonyl)-3-n-butylurea].
    BICKEL G; KORALNIK O
    Schweiz Med Wochenschr; 1959 Nov; 89():1186-91. PubMed ID: 13800475
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pharmacological research on a new hypoglycemic agent: 1-(p-chlorobenzensulfonyl)-3-propyl-urea].
    BRUNORI F; DELL'OMODARME G
    Gazz Med Ital; 1960 May; 119():279-88. PubMed ID: 13848137
    [No Abstract]   [Full Text] [Related]  

  • 17. Search for potent hypoglycaemic agents. II. Mode of action of synthetic hypoglycaemic agents (biguanides).
    PAUL SP; BOSE AN
    Indian J Physiol Pharmacol; 1962 Jan; 6():38-46. PubMed ID: 14484489
    [No Abstract]   [Full Text] [Related]  

  • 18. [Dependency of serum concentration and blood sugar effect of N-4-methylbenzene-sulfonyl-N-butylurea (rastinon, D 860, artosin) on dosage in prolonged intravenous infusions].
    HASSELBLATT A; BLUDAU W
    Klin Wochenschr; 1958 Feb; 36(4):157-63. PubMed ID: 13540141
    [No Abstract]   [Full Text] [Related]  

  • 19. The pharmacology of oral hypoglycaemic agents.
    MACCANNELL KL
    Manit Med Rev; 1961 Nov; 41():584-7. PubMed ID: 14467753
    [No Abstract]   [Full Text] [Related]  

  • 20. Potential antidiabetics. 8. 4-Arylhydrazono-N'-guanylnitrate-3-methyl-2-pyrazolin-5-ones, 4-arylazo-N'-guanylnitrate-3,5-dimethylpyrazoles, and 4-arylazo-N'-guanylnitrate-3,5-diphenylpyrazoles.
    Garg HG; Prakash C
    J Pharm Sci; 1971 Feb; 60(2):323-5. PubMed ID: 5572469
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.